Mylotarg and blood bilirubin increased 
Mylotarg and blood bilirubin increased Patient Reports February 12, 2012
Mylotarg Side Effects Report #4928531-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2006. Male patient, 57 years of age, weighting 204.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, blood bilirubin increased, blood sodium decreased, chromaturia, condition aggravated, discomfort, eating disorder , epistaxis. Mylotarg dosage: 6 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, POTASSIUM CHLORIDE, PREVACID, COMPAZINE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4957371-7
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2006. Male patient, 57 years of age, weighting 204.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, blood bilirubin increased, blood sodium decreased, chromaturia, condition aggravated, discomfort, disease progression, epistaxis. Mylotarg dosage: 6 MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, POTASSIUM CHLORIDE, PREVACID, COMPAZINE. Patient was hospitalized. Patient died on 03/10/2006.Mylotarg Side Effects Report #4969531-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 24, 2006. Male patient, 57 years of age, weighting 204.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, blood bilirubin increased, blood sodium decreased, chromaturia, condition aggravated, discomfort, disease progression, epistaxis. Mylotarg dosage: 6 MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, POTASSIUM CHLORIDE, PREVACID, COMPAZINE. Patient was hospitalized. Patient died on 03/10/2006.Mylotarg Side Effects Report #5353522-3
Mylotarg side effect was reported by a Pharmacist from UNITED STATES on June 08, 2007. Male patient, 67 years of age, weighting 234.0 lb, was diagnosed with leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase increased, ascites, asthenia, blood bilirubin increased, fatigue, hypotension, neutropenia, portal vein thrombosis. Mylotarg dosage: 20MG EA. DOSE -14-DAYS APART- Q14 DAYS IV. Patient died on 09/01/2006.Mylotarg Side Effects Report #4608534-1
Mylotarg side effect was reported by a Pharmacist from on Mar 11, 2005. Male patient was diagnosed with leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood phosphorus increased, weight increased. Mylotarg dosage: 4MG INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5168372-0
Mylotarg side effect was reported by a Health Professional from JAPAN on Nov 21, 2006. Male patient, 80 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, neutrophil count decreased, sepsis
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with ZYVOX, AZACTAM, CIPROXAN, AMIKACIN. Patient died.Mylotarg Side Effects Report #5196079-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 07, 2006. Female patient, 72 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood bilirubin increased, disseminated intravascular coagulation, lymphocyte percentage decreased, lymphocyte percentage increased, neutrophil percentage decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FAMOTIDINE, ASPARA K, ITRACONAZOLE, SULFAMETHOXAZOLE, BIOFERMIN. Patient died.
Mylotarg Side Effects Report #5119945-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 22, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, gamma-glutamyltransferase increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, DIFLUCAN, CLARITHROMYCIN, FAMOTIDINE, MUCOSTA, FEPRAZONE. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5043092-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 15, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, hepatic function abnormal, infection
, interstitial lung disease. Mylotarg dosage: 9 MG/M^2 1 PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with POLYMYXIN B SULPHATE, RABEPRAZOLE, NEUTROGIN. Patient died.Mylotarg Side Effects Report #5202114-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 25, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, LEVOFLOXACIN, DIFLUCAN, ETOPOSIDE, SULPERAZON. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #5110872-3
Mylotarg side effect was reported by a Health Professional from JAPAN on Sept 06, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood pressure decreased, blood urea increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, CRAVIT, DIFLUCAN, ETOPOSIDE, SULPERAZON. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5158276-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 10, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN HYDROCHLORIDE, LEVOFLOXACIN, DIFLUCAN, ETOPOSIDE, SULPERAZON. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4992456-0
Mylotarg side effect was reported by a Health Professional from JAPAN on Apr 19, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, infection
, liver disorder, multi-organ failure, renal disorder. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACLACINON. Patient died.Mylotarg Side Effects Report #5220632-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2007. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, depression
, haematocrit decreased, haemoglobin decreased, hepatic function abnormal, insomnia, intraocular pressure increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with INSULIN, POLYMYXIN B SULPHATE, ITRACONAZOLE, FAMOTIDINE, MUCOSTA, PREDNISOLONE, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5104160-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2006. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood pressure decreased, body temperature decreased, disseminated intravascular coagulation, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with OMEPRAZOLE, MAXIPIME, AMIKACIN SULPHATE, MEROPENEM, TIENAM, CIPROXAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5151889-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 31, 2006. Male patient, 51 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cellulitis
, disseminated intravascular coagulation, dysphagia. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with CYTARABINE, NOVANTRONE, POLYMYXIN B SULPHATE, FAMOTIDINE, SULFAMETHOXAZOLE, ALLORINE, VFEND. Patient was hospitalized. Patient died.Mylotarg Side Effects Report #5113914-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 08, 2006. Female patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood bilirubin increased, disease progression, hepatomegaly, lung injury, mouth haemorrhage, platelet count decreased, pseudomonal sepsis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, HYDREA, CIPROXAN, SULPERAZON, TOBRAMYCIN SULPHATE, FUNGUARD, VFEND, ZOVIRAX. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4851395-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 25, 2005. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: agranulocytosis, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, liver disorder. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX, OMEPRAZOLE. Patient recovered.
Mylotarg Side Effects Report #4930068-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 16, 2006. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, agranulocytosis, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, liver disorder, lymphocyte percentage increased, malignant neoplasm progression, monocyte percentage decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with CYTARABINE, BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX. Patient recovered.
Mylotarg Side Effects Report #4953986-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 10, 2006. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, agranulocytosis, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, lymphocyte percentage increased, malignant neoplasm progression, monocyte percentage increased. Mylotarg dosage: A SINGLE 9 MG/M2 DOSE. During the same period patient was treated with CYTARABINE, BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX. Patient recovered.
Mylotarg Side Effects Report #4995945-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 21, 2006. Female patient, 43 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, agranulocytosis, anaemia, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, malignant neoplasm progression, monocyte percentage decreased, neutrophil percentage decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with BESTATIN, MEROPEN, VANCOMYCIN HYDROCHLORIDE, PRODIF, ZOVIRAX. Patient recovered.
Mylotarg Side Effects Report #5235843-8
Mylotarg side effect was reported by a Physician from JAPAN on Jan 31, 2007. Male patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, disseminated intravascular coagulation, dyspnoea, fall
. Mylotarg dosage: unknown. During the same period patient was treated with LENDORMIN, ARTIST, TAKEPRON, MUCOSTA. Patient recovered.Mylotarg Side Effects Report #5251332-9
Mylotarg side effect was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, AMIKACIN SULPHATE, TIENAM, CIPROFLOXACIN, OMEPRAL, MEROPENEM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5253016-X
Mylotarg side effect was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, AMIKACIN SULPHATE, TIENAM, CIPROFLOXACIN, OMEPRAL, MEROPENEM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5259683-9
Mylotarg side effect was reported by a Physician from JAPAN on Feb 27, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, condition aggravated, pharyngitis, platelet count decreased, pneumonia
, sepsis , septic shock, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, FUNGUARD, CYTARABINE, ITRACONAZOLE, OMEGACIN, BAKTAR, METHOTREXATE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5272838-2
Mylotarg side effect was reported by a Physician from JAPAN on Mar 20, 2007. Male patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, condition aggravated, pharyngitis, platelet count decreased, pneumonia
, sepsis , septic shock. Mylotarg dosage: unknown. During the same period patient was treated with VANCOMYCIN, FUNGUARD, CYLOCIDE, ITRACONAZOLE, OMEGACIN, BAKTAR, METHOTREXATE. Patient was hospitalized and became disabled. Patient recovered.Mylotarg Side Effects Report #5291882-2
Mylotarg side effect was reported by a Physician from JAPAN on Mar 29, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5303031-2
Mylotarg side effect was reported by a Physician from JAPAN on Apr 13, 2007. Male patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia recurrent, hyperlipidaemia, diabetes mellitus, constipation
, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, agranulocytosis, ascites, atelectasis, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, chest x-ray abnormal, cholestasis. Mylotarg dosage: unknown. During the same period patient was treated with LIPITOR, ACTOS, MAGNESIUM OXIDE, HUMULIN, BACTRIM, POLYMYXIN B SULPHATE, FUNGIZONE. Patient was hospitalized. Patient died on 01/18/2007.Mylotarg Side Effects Report #5315496-0
Mylotarg side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, chills. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5343683-4
Mylotarg side effect was reported by a Physician from JAPAN on May 25, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, ascites, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, leucine aminopeptidase increased, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5397497-X
Mylotarg side effect was reported by a Physician from JAPAN on July 19, 2007. Female patient, weighting 101.4 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, febrile neutropenia, sepsis
, venoocclusive liver disease. Mylotarg dosage: unknown. Patient died on 06/01/2007.Mylotarg Side Effects Report #5448630-2
Mylotarg side effect was reported by a Physician from JAPAN on Sept 06, 2007. Female patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia, neutrophil count decreased, performance status decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with MODACIN, ITRIZOLE, FAMOTIDINE, ZOVIRAX, BAKTAR. Patient recovered.
Mylotarg Side Effects Report #5511142-1
Mylotarg side effect was reported by a Physician from JAPAN on Oct 30, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood pressure diastolic increased, disease progression, gamma-glutamyltransferase increased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, OMEPRAZOLE, PROGRAF, UNIPHYL, BEZATOL, PREDONINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5522454-X
Mylotarg side effect was reported by a Physician from JAPAN on Nov 15, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, neutrophil count decreased, sepsis
, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with AMIKACIN, CIPROFLOXACIN, ZYVOX, AZACTAM. Patient died on 11/10/2006.Mylotarg Side Effects Report #5661546-1
Mylotarg side effect was reported by a Physician from JAPAN on Feb 29, 2008. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, neutrophil count decreased, pseudomonas infection, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, OMEPRAL, PROGRAF, UNIPHYL, BEZATOL, PREDONINE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5805078-6
Mylotarg side effect was reported by a Physician from JAPAN on July 03, 2008. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, neutrophil count decreased, sepsis
, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with AMIKACIN, CIPROFLOXACIN, ZYVOX, AZACTAM. Patient died on 11/10/2006.Mylotarg Side Effects Report #5822128-1
Mylotarg side effect was reported by a Physician from JAPAN on July 16, 2008. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.
Mylotarg Side Effects Report #5825801-4
Mylotarg side effect was reported by a Physician from JAPAN on July 24, 2008. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, neutrophil count decreased, pseudomonas infection, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with COTRIM, OMEPRAL, PROGRAF, UNIPHYL, BEZATOL, PREDONINE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5962958-9
Mylotarg side effect was reported by a Physician from JAPAN on Nov 13, 2008. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, condition aggravated, graft versus host disease, neutrophil count decreased, obliterative bronchiolitis, pseudomonas infection, sepsis
. Mylotarg dosage: unknown. During the same period patient was treated with COTRIM, OMEPRAL, PROGRAF, UNIPHYL, BEZATOL, PREDONINE. Patient was hospitalized. Patient died on 05/08/2007.Mylotarg Side Effects Report #5971499-4
Mylotarg side effect was reported by a Physician from JAPAN on Nov 19, 2008. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.
Mylotarg Side Effects Report #6054475-5
Mylotarg side effect was reported by a Physician from JAPAN on Jan 21, 2009. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatomegaly, hypoalbuminaemia. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient died on 12/09/2007.
Mylotarg Side Effects Report #6130073-X
Mylotarg side effect was reported by a Physician from JAPAN on Mar 19, 2009. Male patient, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia recurrent, anxiety
, insomnia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood urea increased, hypoalbuminaemia, neutropenia, pneumonia , thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with DEPAS, SILECE, ACLACINON, CRAVIT. Patient was hospitalized. Patient died on 08/10/2007.Mylotarg Side Effects Report #5007450-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2006. Female patient, 85 years of age, was diagnosed with acute myeloid leukaemia, sepsis
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood urea increased, disease progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CARBENIN, CIPROFLOXACIN, FOSMICIN S, FOSMICIN S, FUNGUARD, MAXIPIME. Patient recovered.Mylotarg Side Effects Report #5105261-1
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Aug 28, 2006. Female patient, 77 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, apparent life threatening event, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood bilirubin increased, bronchoalveolar lavage abnormal, culture positive, haemoptysis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ELSPAR, CYTARABINE, NOVANTRONE. Patient was hospitalized. Patient died on 02/06/2006.Mylotarg Side Effects Report #4870092-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2002. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, disease progression, platelet count decreased, pneumonia fungal. Mylotarg dosage: 8.297 MG 1X PER 1 DAY, INTRAVENOUS; 5.53 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ACYCLOVIR, PERIDEX, PREVACID, FLUCONAZOLE, GENTAMICIN, LEVOFLOXACIN. Patient died on 09/05/2002.
Mylotarg Side Effects Report #4943365-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2006. Male patient, 77 years of age, weighting 160.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased. Mylotarg dosage: 16.5 MG 1X PER 1 DAY, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #4969295-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2006. Female patient, 77 years of age, weighting 136.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood bilirubin increased, haemoptysis, neutrophil count decreased, pneumonia fungal, pyrexia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ELSPAR, CYTARABINE, NOVANTRONE. Patient was hospitalized. Patient died on 02/06/2006.Mylotarg Side Effects Report #4973910-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2006. Male patient, 77 years of age, weighting 161.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased. Mylotarg dosage: 16.5 MG 1X PER 1 DAY, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #4974006-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2006. Male patient, 77 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aspartate aminotransferase increased, blast cell count increased, blood albumin decreased, blood bilirubin increased, blood glucose increased, blood potassium decreased, body temperature increased, csf protein increased. Mylotarg dosage: 16.5 MG 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with FOLIC ACID, ACYCLOVIR, NORVASC, ACCUPRIL, ATENOLOL, VITAMINS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5110577-9
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 08, 2006. Male patient, 76 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, bacteraemia, blood bilirubin increased, blood product transfusion dependent, clostridium difficile colitis, hepatomegaly, jaundice
. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient died on 09/10/2006.Mylotarg Side Effects Report #4949325-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 76 years of age, weighting 214.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chills, disease progression, infusion related reaction, weight increased. Mylotarg dosage: 17 MG, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #5082275-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2006. Male patient, 75 years of age, weighting 156.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, febrile neutropenia, pancytopenia. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISONE, LEVOXYL, DYAZIDE, CELEBREX, RESTORIL. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5085880-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2006. Male patient, 75 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood bilirubin increased, body temperature increased, cholelithiasis, febrile neutropenia, fluid retention, hepatomegaly, liver tenderness, pancytopenia. Mylotarg dosage: unknown. During the same period patient was treated with PREDNISONE, LEVOXYL, DYAZIDE, CELEBREX, RESTORIL. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4947765-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 75 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, chills, hypotension, infusion related reaction, oxygen saturation decreased, pyrexia. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS; SEE IMAGE. Patient recovered.
Mylotarg Side Effects Report #4952749-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 23, 2004. Male patient, 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, febrile neutropenia, pancytopenia. Mylotarg dosage: unknown. During the same period patient was treated with PRDNISONE, DYAZIDE, CELEBREX, RESTORIL. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5091413-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 18, 2006. Male patient, 74 years of age, weighting 137.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myocardial infarction, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, chills, disease progression, hypotension, infusion related reaction. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 04/16/2005.
Mylotarg Side Effects Report #5062296-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2006. Male patient, 73 years of age, weighting 192.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood chloride decreased, haematocrit decreased, haemoglobin decreased, nausea
, platelet count decreased, red blood cell count decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with LEVAQUIN, PROTONIX, DIOVAN, ACYLOVIR, REGLAN, DIFLUCAN, CELEXA, ATIVAN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5105259-3
Mylotarg side effect was reported by a Health Professional from UNITED STATES on July 05, 2006. Female patient, 72 years of age, weighting 152.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood bilirubin increased, crohn's disease
, fibrin d dimer increased, gallbladder disorder, gastrointestinal haemorrhage, haematochezia, international normalised ratio increased, platelet count decreased. Mylotarg dosage: 9 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, IDARUBICIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4897213-1
Mylotarg side effect was reported by a Health Professional from JAPAN on Jan 18, 2006. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebral haemorrhage, febrile neutropenia, glucose urine present, hypertension. Mylotarg dosage: 9 MG/M^2 1 X PER 1 DAY, INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with MERCAPTOPURINE, CYTARABINE, RANIMUSTINE, ADETPHOS. Patient died.
Mylotarg Side Effects Report #4960536-1
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Mar 31, 2006. Female patient, 71 years of age, weighting 192.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dyspnoea, weight increased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4976163-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 03, 2006. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebral haemorrhage, condition aggravated, febrile neutropenia, glucose urine present, hepatic function abnormal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, RANIMUSTINE, ADETPHOS. Patient died.
Mylotarg Side Effects Report #4978538-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2006. Female patient, 71 years of age, weighting 192.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, disease progression, dyspnoea, weight increased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5052858-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase, bone marrow transplant
, chills, dehydration. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.Mylotarg Side Effects Report #5056539-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, bone marrow transplant
, chills. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.Mylotarg Side Effects Report #5107064-0
Mylotarg side effect was reported by a Physician from UNITED STATES on Aug 31, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alveolitis, atelectasis, bilirubin conjugated increased, blood bilirubin increased, blood count abnormal, blood ph increased, bronchial disorder, candidiasis. Mylotarg dosage: 10 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NOVANTRONE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5122419-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 29, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alveolitis, apparent life threatening event, atelectasis, blood bilirubin increased, blood ph increased, cardiac disorder, cardiac failure congestive, dilatation atrial. Mylotarg dosage: unknown. During the same period patient was treated with NOVANTRONE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4627225-4
Mylotarg side effect was reported by a Consumer or non-health professional from on Mar 18, 2005. Male patient, 70 years of age, weighting 180.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: apnoea, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, chills, condition aggravated, dyspnoea, hyperhidrosis. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NEXIUM, OXYCODONE, NEURONTIN, MORPHINE SULPHATE, AMBIEN, TYLENOL, ZOSYN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4744368-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2005. Male patient, 69 years of age, weighting 179.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, pyrexia, weight increased. Mylotarg dosage: unknown. Patient recovered.
Mylotarg Side Effects Report #4942640-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2006. Male patient, 69 years of age, weighting 276.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood bilirubin increased, blood creatinine increased, blood urea increased, chills, cholelithiasis, dry mouth. Mylotarg dosage: 21 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN. Patient was hospitalized. Patient died on 05/06/2004.
Mylotarg Side Effects Report #4952627-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 69 years of age, weighting 179.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, angiopathy, ascites, aspartate aminotransferase increased, blood bilirubin increased, gallbladder disorder, infusion related reaction, liver disorder, liver function test abnormal. Mylotarg dosage: unknown. Patient recovered.
Mylotarg Side Effects Report #5049381-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2006. Female patient, 68 years of age, weighting 196.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, diarrhoea, hepatic enzyme increased, hypotension, hypovolaemia, renal failure acute. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with BACTRIM, CIPRO, COMPAZINE, ACYCLOVIR, FLUCONAZOLE, ALLOPURINOL, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient died on 10/08/2005.
Mylotarg Side Effects Report #4658409-7
Mylotarg side effect was reported by a Consumer or non-health professional from on Apr 26, 2005. Female patient, 68 years of age, weighting 184.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood culture positive, cardiac arrest
, cellulitis , chest x-ray abnormal, febrile neutropenia, haematoma, herpes simplex . Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient died on 05/14/2004.Mylotarg Side Effects Report #4672905-8
Mylotarg side effect was reported by a Health Professional from on May 10, 2005. Female patient, 68 years of age, weighting 184.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: agitation, blood bilirubin increased, blood culture positive, cardiac arrest
, cellulitis , chest x-ray abnormal, culture urine positive, delirium, disorientation. Mylotarg dosage: 12 MG 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient died on 05/14/2004.Mylotarg Side Effects Report #4681377-9
Mylotarg side effect was reported by a Consumer or non-health professional from on May 19, 2005. Female patient, 68 years of age, weighting 161.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, aspartate aminotransferase increased, bacteraemia, blood alkaline phosphatase increased, blood bilirubin increased, chills, decreased appetite, dyspnoea, enterobacter infection. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ACYCLOVIR, PROTONIX. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4693909-5
Mylotarg side effect was reported by a Consumer or non-health professional from on June 07, 2005. Female patient, 68 years of age, weighting 183.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: agitation, blood bilirubin increased, blood culture positive, cardiac arrest
, cellulitis , condition aggravated, culture urine positive, delirium, disorientation. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, GUAIFENESIN, MEGACE, CEFTAZIDIME, PROTONIX, ACYCLOVIR. Patient was hospitalized. Patient died on 05/14/2004.Mylotarg Side Effects Report #4822191-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2005. Female patient, 68 years of age, weighting 196.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hypotension, hypovolaemia, lung infiltration, renal failure acute, renal tubular necrosis. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENUOUS. During the same period patient was treated with BACTRIM, CIPRO, COMPAZINE, ACYCLOVIR, FLUCONAZOLE, ALLOPURINOL, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient died on 10/08/2005.
Mylotarg Side Effects Report #4990681-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 14, 2006. Female patient, 68 years of age, weighting 196.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic enzyme increased, hypotension, hypovolaemia, renal failure acute, renal tubular necrosis. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with BACTRIM, CIPRO, COMPAZINE, ACYCLOVIR, FLUCONAZOLE, ALLOPURINOL, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient died on 10/08/2005.
Mylotarg Side Effects Report #4754314-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 19, 2005. Female patient, 67 years of age, weighting 117.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dyspnoea, hepatotoxicity, malignant neoplasm progression, pleural effusion. Mylotarg dosage: 9.1 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 04/03/2004.
Mylotarg Side Effects Report #5092802-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 17, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, disease progression, haemolytic anaemia, haemorrhagic diathesis, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with DIFLUCAN, ISONIAZID, STREPTOMYCIN SULPHATE, FUNGUARD, MEROPEN, NEUPOGEN, PREDNISOLONE. Patient died.
Mylotarg Side Effects Report #5128900-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2006. Female patient, 66 years of age, weighting 151.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, febrile neutropenia, fluid overload, haemoglobin decreased, infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPRO, DIFLUCAN, ACYCLOVIR, PROZAC, LOPRESSOR, PREVACID, COUMADIN. Patient was hospitalized. Patient died on 07/19/2003.
Mylotarg Side Effects Report #4949624-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 66 years of age, weighting 151.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood urea increased, disease progression, febrile neutropenia, fluid overload, haemoglobin decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, DIFLUCAN, ACYCLOVIR, PROZAC, LOPRESSOR, PREVACID, COUMADIN. Patient was hospitalized. Patient died on 07/19/2003.
Mylotarg Side Effects Report #5073159-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, disease progression, dyspnoea. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.
Mylotarg Side Effects Report #5106489-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, decreased appetite, dizziness
, dyspnoea. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.Mylotarg Side Effects Report #5119380-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, disease progression. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.
Mylotarg Side Effects Report #5122893-5
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Sept 27, 2006. Male patient, 65 years of age, weighting 212.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase decreased, blood alkaline phosphatase increased, blood bilirubin increased, weight increased. Mylotarg dosage: 19 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with IMIPENEM, TOBRAMYCIN, REGLAN, ACETAMINOPHEN, GUAIFENESIN, PERCOCET, ACYCLOVIR. Patient recovered.
Mylotarg Side Effects Report #4553398-8
Mylotarg side effect was reported by a Consumer or non-health professional from on Jan 06, 2005. Male patient, 65 years of age, weighting 166.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood chloride increased, blood urea increased, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 18.6 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4570073-4
Mylotarg side effect was reported by a Consumer or non-health professional from on Jan 17, 2005. Male patient, 65 years of age, weighting 166.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood bilirubin increased, blood chloride increased, blood urea increased, haemolysis, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 18.6 MG 1 X PER 1 DAY, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #4867672-9
Mylotarg side effect was reported by a Physician from UNITED STATES on Apr 13, 2005. Female patient, 64 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood albumin decreased, blood bilirubin increased, blood lactate dehydrogenase increased, bronchopneumonia, cardiopulmonary failure. Mylotarg dosage: 9 MG/M(2) (DOSE: 15 MG], INTRAVENOUS. During the same period patient was treated with HYDREA. Patient was hospitalized. Patient died on 06/13/1999.
Mylotarg Side Effects Report #4706836-1
Mylotarg side effect was reported by a Physician from UNITED STATES on Nov 11, 2004. Male patient, 63 years of age, weighting 235.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, chills, delirium, depression
, diarrhoea, disease progression, disease recurrence, febrile neutropenia. Mylotarg dosage: 9 MG/M(2) ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, LEVOFLOXACIN, FLUCONAZOLE, ACYCLOVIR, IMIPENEM, FLAGYL, LACTAID. Patient was hospitalized and became disabled. Patient died on 06/26/2002.Mylotarg Side Effects Report #4809726-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 02, 2004. Male patient, 63 years of age, weighting 235.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, chest x-ray abnormal, chills, delirium, depression
, diarrhoea, disease progression, febrile neutropenia. Mylotarg dosage: unknown. During the same period patient was treated with ALLOPURINOL, FLUCONAZOLE, ACYCLOVIR, IMIPENEM. Patient was hospitalized and became disabled. Patient died on 06/26/2002.Mylotarg Side Effects Report #5008804-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 11, 2006. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, activated partial thromboplastin time prolonged, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blast cell count increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with METHOTREXATE, OMEGACIN. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5081539-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Male patient, 62 years of age, weighting 160.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood bilirubin increased, blood calcium decreased, fluid overload, hypovolaemia, pneumonia
, renal failure acute, respiratory distress. Mylotarg dosage: A SINGLE 10 MG DOSE , INTRAVENOUS. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE. Patient died on 12/29/2004.Mylotarg Side Effects Report #5105193-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2006. Male patient, 62 years of age, weighting 160.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood bilirubin increased, blood calcium decreased, carbon dioxide decreased, disease progression, dyspnoea, fluid overload, hypovolaemia. Mylotarg dosage: A SINGLE 10 MG, DOSE, INTRAVENOUS; 11 MG, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE, PANTOPRAZOLE, ACYCLOVIR, ACETAMINOPHEN, DIPHENHYDRAMINE, LORAZEPAM. Patient died on 12/29/2004.
Mylotarg Side Effects Report #4840173-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 10, 2005. Male patient, 62 years of age, weighting 183.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, hepatic enzyme increased, pneumonia fungal, pulmonary oedema. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS. During the same period patient was treated with LASIX, ETOPOSIDE, CYTOXAN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4951677-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 62 years of age, weighting 198.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chills, dyspnoea, infusion related reaction, pyrexia, weight increased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #4658365-1
Mylotarg side effect was reported by a Consumer or non-health professional from on Apr 26, 2005. Male patient, 61 years of age, weighting 186.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood culture positive, catheter related infection, chills, dyspnoea, epistaxis, fatigue, febrile neutropenia, haematocrit decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4720752-0
Mylotarg side effect was reported by a Physician from UNITED STATES on July 05, 2005. Male patient, 60 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, body temperature increased, pancytopenia, pyrexia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, CIPRO, CARDIZEM, BENADRYL, SPORANOX, PROTONIX, ZOSYN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4948798-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 287.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, blood pressure increased, dialysis
, disease progression, hepatic steatosis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with INSULIN, ACYCLOVIR, ALLOPURINOL, NORVASC, FIBRALAX, CIPROFLOXACIN, KLONOPIN. Patient was hospitalized. Patient died on 11/01/2003.Mylotarg Side Effects Report #4949643-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 186.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, catheter related infection, chills, dyspnoea, epistaxis, fatigue, febrile neutropenia, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5217084-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 09, 2007. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, condition aggravated, pharyngitis, platelet count decreased, pneumonia
, septic shock, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with MAXIPIME, VANCOMYCIN, FUNGUARD, TIENAM, ITRACONAZOLE, OMEGACIN, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4744989-X
Mylotarg side effect was reported by a Physician from UNITED STATES on Aug 03, 2005. Male patient, 58 years of age, weighting 212.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, beta haemolytic streptococcal infection, blood alkaline phosphatase increased, blood bilirubin increased, blood culture positive, malignant neoplasm progression, oedema peripheral, sepsis
. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with AVANDIA, SPORANOX, CIPRO, KEFLEX, VALCYTE, FOLIC ACID, DIGOXIN. Patient was hospitalized. Patient died on 09/07/2003.